Mon, Jul 15, 2013 at 09:08
Target: Rs 2,125
Rationale: The approval for Dacogen is positive given the uncertainty over FDA approval timelines & the impact that it can have on street estimates for Dr Reddy's.
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.